Bala Vamsi Karuturi
About Bala Vamsi Karuturi
Bala Vamsi Karuturi is an Associate Director of Manufacturing Science and Technology at Deciphera Pharmaceuticals, with extensive experience in pharmaceutical sciences, particularly in vaccine formulations and solid oral dosage forms.
Work at Deciphera Pharmaceuticals
Bala Vamsi Karuturi currently serves as the Associate Director of Manufacturing Science and Technology at Deciphera Pharmaceuticals. He has held this position since 2021 and is based in the Greater Boston area. In this role, he focuses on advancing manufacturing processes and technologies to support the development of therapeutic products.
Previous Experience at Mylan
Karuturi worked at Mylan in various capacities from 2015 to 2019. He initially served as a Process Development Scientist in Manufacturing Technical Services for Solid Oral Dosage Forms for three years. He then transitioned to the role of Senior Scientist in Process Development for one year in Morgantown, West Virginia. His work involved the development and optimization of manufacturing processes.
Education and Expertise
Karuturi earned his Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences from the University of Nebraska Medical Center, where he studied from 2008 to 2014. His doctoral research focused on developing biodegradable subunit-based nanoparticulate mucosal vaccines against cytomegalovirus infection. He also holds a Bachelor of Science (B.S.) in Pharmaceutical Sciences from Andhra University, completed from 2004 to 2008.
Background in Pharmaceutical Sciences
Bala Vamsi Karuturi has a strong background in pharmaceutical sciences, particularly in immunology and vaccine formulations. His experience includes working as a Graduate Research Fellow at the University of Nebraska Medical Center for six years and as a Product Development Scientist at ProTransit Nanotherapy for one year. Additionally, he served as a Technical Operations Manager at Vertex Pharmaceuticals from 2019 to 2021.
Solid Oral Dosage Form Development
Karuturi has significant experience in the development of solid oral dosage forms. His expertise in this area has been applied throughout his career, particularly during his tenure at Mylan and in his current role at Deciphera Pharmaceuticals. This experience contributes to his ability to enhance manufacturing processes and ensure product quality.